260 related articles for article (PubMed ID: 15716405)
1. Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.
Boska MD; Lewis TB; Destache CJ; Benner EJ; Nelson JA; Uberti M; Mosley RL; Gendelman HE
J Neurosci; 2005 Feb; 25(7):1691-700. PubMed ID: 15716405
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.
Benner EJ; Mosley RL; Destache CJ; Lewis TB; Jackson-Lewis V; Gorantla S; Nemachek C; Green SR; Przedborski S; Gendelman HE
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9435-40. PubMed ID: 15197276
[TBL] [Abstract][Full Text] [Related]
3. Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson's Disease via Peroxisome Proliferator-Activated Receptorα.
Prorok T; Jana M; Patel D; Pahan K
Neurochem Res; 2019 Apr; 44(4):751-762. PubMed ID: 30612307
[TBL] [Abstract][Full Text] [Related]
4. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.
Gao L; Díaz-Martín J; Dillmann WH; López-Barneo J
Neuroscience; 2011 Oct; 193():323-9. PubMed ID: 21782904
[TBL] [Abstract][Full Text] [Related]
6. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
Bezard E; Jaber M; Gonon F; Boireau A; Bloch B; Gross CE
Eur J Neurosci; 2000 Aug; 12(8):2892-900. PubMed ID: 10971632
[TBL] [Abstract][Full Text] [Related]
7. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
Breidert T; Callebert J; Heneka MT; Landreth G; Launay JM; Hirsch EC
J Neurochem; 2002 Aug; 82(3):615-24. PubMed ID: 12153485
[TBL] [Abstract][Full Text] [Related]
8. Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism.
Xu M; Bohlen JK; Moore C; Nipper MA; Finn DA; Jones CE; Lim MM; Meshul CK
J Neurosci Res; 2019 Dec; 97(12):1706-1719. PubMed ID: 31535395
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice through modulating mitochondrial dynamics.
Lee SB; Youn J; Jang W; Yang HO
Neurochem Int; 2019 Oct; 129():104491. PubMed ID: 31229553
[TBL] [Abstract][Full Text] [Related]
11. RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.
Dutta D; Kundu M; Mondal S; Roy A; Ruehl S; Hall DA; Pahan K
Neurobiol Dis; 2019 Dec; 132():104575. PubMed ID: 31445159
[TBL] [Abstract][Full Text] [Related]
12. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
13. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
Kim S; Moon M; Park S
J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Laurie C; Reynolds A; Coskun O; Bowman E; Gendelman HE; Mosley RL
J Neuroimmunol; 2007 Feb; 183(1-2):60-8. PubMed ID: 17196666
[TBL] [Abstract][Full Text] [Related]
16. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F
J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273
[TBL] [Abstract][Full Text] [Related]
17. Neurometabolic profiles of the substantia nigra and striatum of MPTP-intoxicated common marmosets: An in vivo proton MRS study at 9.4 T.
Heo H; Ahn JB; Lee HH; Kwon E; Yun JW; Kim H; Kang BC
NMR Biomed; 2017 Feb; 30(2):. PubMed ID: 28028868
[TBL] [Abstract][Full Text] [Related]
18. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
[TBL] [Abstract][Full Text] [Related]
19. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
Santos DB; Colle D; Moreira EL; Hort MA; Godoi M; Le Douaron G; Braga AL; Assreuy J; Michel PP; Prediger RD; Raisman-Vozari R; Farina M
Mol Neurobiol; 2017 Mar; 54(2):1513-1530. PubMed ID: 26852411
[TBL] [Abstract][Full Text] [Related]
20. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
Zhang J; Graham DG; Montine TJ; Ho YS
J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
